COLUMBIA, Md., Sept. 10 — A top 5 bio-pharmaceutical company has licensed BioFortis’ Labmatrix(TM) software for use enterprise-wide, across multiple therapeutic areas within its global Translational Medicine organization, BioFortis officials announced today. This large biopharmaceutical company decided to adopt the Labmatrix technology after an extensive review process that included a pilot by end users and […]
GE Healthcare Financial Services has provided a $3 million Senior Secured Credit Facility to Codon Devices, the Constructive Biology(TM) Company–a privately-held biotechnology firm delivering products and platform solutions based on synthetic biology to the chemical industry. The financing will be used for growth and other working capital needs. “GE Healthcare Financial Services tailored a financing […]
HOPKINTON, Mass., Sept. 9 — Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today introduced the IVIS(R) Kinetic preclinical in vivo imaging system. The system enables researchers to non-invasively view biological events at the molecular level as they occur in real-time. The IVIS […]
9 September 2008 – Sydney, Australia: Fluorotechnics Limited, an Australian company developing and selling fluorescence-based products to the world’s pharmaceutical and biotech companies, has signed a binding agreement to acquire US-based The Gel Company Inc (GelCo) . GelCo is a profitable company providing over 250 products for applications such as proteomics, cell culture, DNA sequencing, […]
Source: Pharsight Corporation ST. LOUIS and MOUNTAIN VIEW, Calif., Sept. 9, 2008 — Tripos, a leading provider of drug discovery informatics products and services, and Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic, and regulatory services designed to optimize clinical drug development, today announced they have entered into a definitive agreement for Pharsight to […]
International Stem Cell (OTCBB:ISCO) announced today it has entered into a worldwide distribution agreement with Millipore Corporation (NYSE: MIL) to manufacture living cells and cell culture products to be sold through Millipore’s distribution network. “To work with a company such as Millipore that has sales of over $1.5 billion and is known throughout the world […]
Optimized synthetic standard genes are now also available for use in insect or mammalian cells Extension of joint offer as response to high number of customer requests from academia and pharmaceutical industry Synthetic standard human genes are optimized and produced by GENEART and sold via QIAGENS´s GeneGlobe web portal Marketing of standardized human genes perfectly […]
Guava Technologies, Inc. has announced that it is in the final stages of development of a series of new bead-based multiplex detection kits for cytokines and chemokines. The development effort is intended to meet the needs of drug discovery researchers focusing on the areas of immunology, inflammation, and oncology. The kits, which will be available […]
TUCSON, Ariz.–HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) system and service partner for the life sciences industry, today announced the appointment of Pete Clemens to Senior Vice President of Commercial Operations. Clemens’ primary responsibility will be leading global sales and commercialization efforts. Clemens joins HTG from Becton Dickinson & Company (BD), worldwide […]
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the appointment of Joe Beery as head of Invitrogen’s Global Information Technology, effective September 8, 2008. “In today’s competitive research environment, success depends upon real-time access to scientific tools and information,” said Greg Lucier, Chairman and Chief Executive […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
